Gaps Between Guidelines and Clinical Practice Patterns in ASCVD

Opinion
Video

Experts on the management of ASCVD discuss clinical practice patterns of high-risk patients and the common reasons for clinicians not intensifying cholesterol treatment.

Related Videos
A panel of 5 experts on ASCVD
A panel of 5 experts on ASCVD
Video 2 - "Identifying Contraindications Before Administering RSV Vaccines"
Video 1 - "Preventing RSV in Adults: Current Vaccination Options"
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Video 2 - "Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care"
Video 1 - "Identifying and Screening for Hepatic Encephalopathy Risk Factors"
Related Content
Managing Pulmonary Arterial Hypertension: Diagnosis, Classification, and Treatment Strategies

Managing Pulmonary Arterial Hypertension: Diagnosis, Classification, and Treatment Strategies

April 30th 2024
Article
Salt in wooden bowl on dark stone table. | Image Credit: Milan - stock.adobe.com

Study Finds Many Individuals With Cardiovascular Disease Consume Twice Daily Recommendation of Sodium

April 22nd 2024
Article
Semaglutide's New Indication Highlights Growing Role of GLP-1 Receptor Agonists

Semaglutide's New Indication Highlights Growing Role of GLP-1 Receptor Agonists

April 16th 2024
Article
SGLT-2 Inhibitors Associated with Reduced Hyperkalemia in Patients With Heart Failure

SGLT-2 Inhibitors Associated with Reduced Hyperkalemia in Patients With Heart Failure

April 15th 2024
Article
3d illustration of human heart and cardiogram on futuristic blue background. | Image Credit: Artem - stock.adobe.com

Real-World Data on Mavacamten Builds on Clinical, Safety Profile

April 15th 2024
Article
Empagliflozin Shows 10% Relative Risk Reduction in Time to First Hospitalization Due to Heart Failure

Empagliflozin Shows 10% Relative Risk Reduction in Time to First Hospitalization Due to Heart Failure

April 8th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.